Global and Regional Anatomic Pathology
Global and Regional Anatomic Pathology

Anatomic Pathology Comprehensive Study by Type (Instruments (Tissue Processors, Microtome, Cryostats, Others), Consumables (Reagents(Stains & Dyes,Fixatives,Others), Antibodies), Histopathology), Application (Diseases Diagnosis, Drug Discovery & Development, Other Applications), End User (Pathology Labs, Research Institutes, Hospitals, Others) Players and Region - Global Market Outlook to 2026

Anatomic Pathology Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Feb 2021 Edition 215 Pages 175 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Anatomic Pathology Market?

Anatomic Pathology is the process of the observation of the organs and tissues to help in knowing the reasons and effects of particular diseases. Anatomic pathology involves the diagnosis of various types of cancer, infectious diseases, and medical conditions through the examination of cells and tissue samples, which are collected from patients through biopsy. The market is witnessing high growth due to an increasing prevalence of chronic diseases and increasing healthcare expenditure. The anatomical pathologist’s conclusions are essential to medical diagnosis, patient management, and research.

The market study is being classified by Type (Instruments (Tissue Processors, Microtome, Cryostats, Others), Consumables (Reagents(Stains & Dyes,Fixatives,Others), Antibodies) and Histopathology), by Application (Diseases Diagnosis, Drug Discovery & Development and Other Applications) and major geographies with country level break-up.

F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (United States), Thermo Fisher Scientific Inc. (United States), Hologic, Inc. (United States), Koninklijke Philips N.V.( Netherlands), Agilent Technologies (United States), Becton, Dickinson, and Company (United States), Sakura Finetek (Japan), Merck KGaA (Germany), Bio SB (United States), Diapath S.p.A. (Italy) and BioGenex Laboratories (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Oxford Cancer Biomarkers Ltd. (United Kingdom), Enzo Biochem Inc. (United States) and Epic Sciences (United States).

The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Anatomic Pathology market throughout the predicted period.

Segment Analysis
Analyst at AMA have segmented the market study of Global Anatomic Pathology market by Type, Application and Region.

On the basis of geography, the market of Anatomic Pathology has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Rising Prevalence of Chronic Diseases
  • Growing Demand for Personalized Medicine

Market Trend
  • Emerging Technology in Medical Device
  • Reagent Rental Agreements

Restraints
  • High Degree of Consolidation in this Industry
  • Stringent Government Regulations Pertaining to Anatomic Pathology

Opportunities
  • High-quality Infrastructure for Hospitals and Clinical Laboratorie
  • Increasing Number of Clinical Trials Pertaining to Cancer Drugs

Challenges
  • Lack of Skilled Professionals


Market Leaders and some development strategies
In Jan 2018, Cancer informatics and digital pathology workflow solution provider Inspirata®, Inc. announced today that it has acquired Pittsburgh, PA-based Omnyx from GE Healthcare.
In Oct 2018, Henry Ford Health System Pathology and Laboratory Medicine announced a research and development partnership with Sakura Finetek USA to increase the automation level of its core anatomic pathology laboratories, thereby increasing the quality of results while reducing turnaround time, minimizing errors, and lessening the need for human intervention.


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Anatomic Pathology Instrument Manufacturer, Anatomic Pathology Instrument Suppliers/Distributors, Raw Material Suppliers, Pathology Service Provider, Government Regulatory and Research Organizations and End-Use Industry

Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Instruments (Tissue Processors, Microtome, Cryostats, Others)
  • Consumables (Reagents(Stains & Dyes,Fixatives,Others), Antibodies)
  • Histopathology
By Application
  • Diseases Diagnosis
  • Drug Discovery & Development
  • Other Applications
By End User
  • Pathology Labs
  • Research Institutes
  • Hospitals
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Prevalence of Chronic Diseases
      • 3.2.2. Growing Demand for Personalized Medicine
    • 3.3. Market Challenges
      • 3.3.1. Lack of Skilled Professionals
    • 3.4. Market Trends
      • 3.4.1. Emerging Technology in Medical Device
      • 3.4.2. Reagent Rental Agreements
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Anatomic Pathology, by Type, Application, End User and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Anatomic Pathology (Value)
      • 5.2.1. Global Anatomic Pathology by: Type (Value)
        • 5.2.1.1. Instruments (Tissue Processors, Microtome, Cryostats, Others)
        • 5.2.1.2. Consumables (Reagents(Stains & Dyes,Fixatives,Others), Antibodies)
        • 5.2.1.3. Histopathology
      • 5.2.2. Global Anatomic Pathology by: Application (Value)
        • 5.2.2.1. Diseases Diagnosis
        • 5.2.2.2. Drug Discovery & Development
        • 5.2.2.3. Other Applications
      • 5.2.3. Global Anatomic Pathology by: End User (Value)
        • 5.2.3.1. Pathology Labs
        • 5.2.3.2. Research Institutes
        • 5.2.3.3. Hospitals
        • 5.2.3.4. Others
      • 5.2.4. Global Anatomic Pathology Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Anatomic Pathology: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. F. Hoffmann-La Roche Ltd. (Switzerland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Danaher Corporation (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Thermo Fisher Scientific Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Hologic, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Koninklijke Philips N.V.( Netherlands)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Agilent Technologies (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Becton, Dickinson, and Company (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Sakura Finetek (Japan)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Merck KGaA (Germany)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Bio SB (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Diapath S.p.A. (Italy)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. BioGenex Laboratories (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
  • 7. Global Anatomic Pathology Sale, by Type, Application, End User and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Anatomic Pathology (Value)
      • 7.2.1. Global Anatomic Pathology by: Type (Value)
        • 7.2.1.1. Instruments (Tissue Processors, Microtome, Cryostats, Others)
        • 7.2.1.2. Consumables (Reagents(Stains & Dyes,Fixatives,Others), Antibodies)
        • 7.2.1.3. Histopathology
      • 7.2.2. Global Anatomic Pathology by: Application (Value)
        • 7.2.2.1. Diseases Diagnosis
        • 7.2.2.2. Drug Discovery & Development
        • 7.2.2.3. Other Applications
      • 7.2.3. Global Anatomic Pathology by: End User (Value)
        • 7.2.3.1. Pathology Labs
        • 7.2.3.2. Research Institutes
        • 7.2.3.3. Hospitals
        • 7.2.3.4. Others
      • 7.2.4. Global Anatomic Pathology Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Anatomic Pathology: by Type(USD Million)
  • Table 2. Anatomic Pathology Instruments (Tissue Processors, Microtome, Cryostats, Others) , by Region USD Million (2015-2020)
  • Table 3. Anatomic Pathology Consumables (Reagents(Stains & Dyes,Fixatives,Others), Antibodies) , by Region USD Million (2015-2020)
  • Table 4. Anatomic Pathology Histopathology , by Region USD Million (2015-2020)
  • Table 5. Anatomic Pathology: by Application(USD Million)
  • Table 6. Anatomic Pathology Diseases Diagnosis , by Region USD Million (2015-2020)
  • Table 7. Anatomic Pathology Drug Discovery & Development , by Region USD Million (2015-2020)
  • Table 8. Anatomic Pathology Other Applications , by Region USD Million (2015-2020)
  • Table 9. Anatomic Pathology: by End User(USD Million)
  • Table 10. Anatomic Pathology Pathology Labs , by Region USD Million (2015-2020)
  • Table 11. Anatomic Pathology Research Institutes , by Region USD Million (2015-2020)
  • Table 12. Anatomic Pathology Hospitals , by Region USD Million (2015-2020)
  • Table 13. Anatomic Pathology Others , by Region USD Million (2015-2020)
  • Table 14. South America Anatomic Pathology, by Country USD Million (2015-2020)
  • Table 15. South America Anatomic Pathology, by Type USD Million (2015-2020)
  • Table 16. South America Anatomic Pathology, by Application USD Million (2015-2020)
  • Table 17. South America Anatomic Pathology, by End User USD Million (2015-2020)
  • Table 18. Brazil Anatomic Pathology, by Type USD Million (2015-2020)
  • Table 19. Brazil Anatomic Pathology, by Application USD Million (2015-2020)
  • Table 20. Brazil Anatomic Pathology, by End User USD Million (2015-2020)
  • Table 21. Argentina Anatomic Pathology, by Type USD Million (2015-2020)
  • Table 22. Argentina Anatomic Pathology, by Application USD Million (2015-2020)
  • Table 23. Argentina Anatomic Pathology, by End User USD Million (2015-2020)
  • Table 24. Rest of South America Anatomic Pathology, by Type USD Million (2015-2020)
  • Table 25. Rest of South America Anatomic Pathology, by Application USD Million (2015-2020)
  • Table 26. Rest of South America Anatomic Pathology, by End User USD Million (2015-2020)
  • Table 27. Asia Pacific Anatomic Pathology, by Country USD Million (2015-2020)
  • Table 28. Asia Pacific Anatomic Pathology, by Type USD Million (2015-2020)
  • Table 29. Asia Pacific Anatomic Pathology, by Application USD Million (2015-2020)
  • Table 30. Asia Pacific Anatomic Pathology, by End User USD Million (2015-2020)
  • Table 31. China Anatomic Pathology, by Type USD Million (2015-2020)
  • Table 32. China Anatomic Pathology, by Application USD Million (2015-2020)
  • Table 33. China Anatomic Pathology, by End User USD Million (2015-2020)
  • Table 34. Japan Anatomic Pathology, by Type USD Million (2015-2020)
  • Table 35. Japan Anatomic Pathology, by Application USD Million (2015-2020)
  • Table 36. Japan Anatomic Pathology, by End User USD Million (2015-2020)
  • Table 37. India Anatomic Pathology, by Type USD Million (2015-2020)
  • Table 38. India Anatomic Pathology, by Application USD Million (2015-2020)
  • Table 39. India Anatomic Pathology, by End User USD Million (2015-2020)
  • Table 40. South Korea Anatomic Pathology, by Type USD Million (2015-2020)
  • Table 41. South Korea Anatomic Pathology, by Application USD Million (2015-2020)
  • Table 42. South Korea Anatomic Pathology, by End User USD Million (2015-2020)
  • Table 43. Taiwan Anatomic Pathology, by Type USD Million (2015-2020)
  • Table 44. Taiwan Anatomic Pathology, by Application USD Million (2015-2020)
  • Table 45. Taiwan Anatomic Pathology, by End User USD Million (2015-2020)
  • Table 46. Australia Anatomic Pathology, by Type USD Million (2015-2020)
  • Table 47. Australia Anatomic Pathology, by Application USD Million (2015-2020)
  • Table 48. Australia Anatomic Pathology, by End User USD Million (2015-2020)
  • Table 49. Rest of Asia-Pacific Anatomic Pathology, by Type USD Million (2015-2020)
  • Table 50. Rest of Asia-Pacific Anatomic Pathology, by Application USD Million (2015-2020)
  • Table 51. Rest of Asia-Pacific Anatomic Pathology, by End User USD Million (2015-2020)
  • Table 52. Europe Anatomic Pathology, by Country USD Million (2015-2020)
  • Table 53. Europe Anatomic Pathology, by Type USD Million (2015-2020)
  • Table 54. Europe Anatomic Pathology, by Application USD Million (2015-2020)
  • Table 55. Europe Anatomic Pathology, by End User USD Million (2015-2020)
  • Table 56. Germany Anatomic Pathology, by Type USD Million (2015-2020)
  • Table 57. Germany Anatomic Pathology, by Application USD Million (2015-2020)
  • Table 58. Germany Anatomic Pathology, by End User USD Million (2015-2020)
  • Table 59. France Anatomic Pathology, by Type USD Million (2015-2020)
  • Table 60. France Anatomic Pathology, by Application USD Million (2015-2020)
  • Table 61. France Anatomic Pathology, by End User USD Million (2015-2020)
  • Table 62. Italy Anatomic Pathology, by Type USD Million (2015-2020)
  • Table 63. Italy Anatomic Pathology, by Application USD Million (2015-2020)
  • Table 64. Italy Anatomic Pathology, by End User USD Million (2015-2020)
  • Table 65. United Kingdom Anatomic Pathology, by Type USD Million (2015-2020)
  • Table 66. United Kingdom Anatomic Pathology, by Application USD Million (2015-2020)
  • Table 67. United Kingdom Anatomic Pathology, by End User USD Million (2015-2020)
  • Table 68. Netherlands Anatomic Pathology, by Type USD Million (2015-2020)
  • Table 69. Netherlands Anatomic Pathology, by Application USD Million (2015-2020)
  • Table 70. Netherlands Anatomic Pathology, by End User USD Million (2015-2020)
  • Table 71. Rest of Europe Anatomic Pathology, by Type USD Million (2015-2020)
  • Table 72. Rest of Europe Anatomic Pathology, by Application USD Million (2015-2020)
  • Table 73. Rest of Europe Anatomic Pathology, by End User USD Million (2015-2020)
  • Table 74. MEA Anatomic Pathology, by Country USD Million (2015-2020)
  • Table 75. MEA Anatomic Pathology, by Type USD Million (2015-2020)
  • Table 76. MEA Anatomic Pathology, by Application USD Million (2015-2020)
  • Table 77. MEA Anatomic Pathology, by End User USD Million (2015-2020)
  • Table 78. Middle East Anatomic Pathology, by Type USD Million (2015-2020)
  • Table 79. Middle East Anatomic Pathology, by Application USD Million (2015-2020)
  • Table 80. Middle East Anatomic Pathology, by End User USD Million (2015-2020)
  • Table 81. Africa Anatomic Pathology, by Type USD Million (2015-2020)
  • Table 82. Africa Anatomic Pathology, by Application USD Million (2015-2020)
  • Table 83. Africa Anatomic Pathology, by End User USD Million (2015-2020)
  • Table 84. North America Anatomic Pathology, by Country USD Million (2015-2020)
  • Table 85. North America Anatomic Pathology, by Type USD Million (2015-2020)
  • Table 86. North America Anatomic Pathology, by Application USD Million (2015-2020)
  • Table 87. North America Anatomic Pathology, by End User USD Million (2015-2020)
  • Table 88. United States Anatomic Pathology, by Type USD Million (2015-2020)
  • Table 89. United States Anatomic Pathology, by Application USD Million (2015-2020)
  • Table 90. United States Anatomic Pathology, by End User USD Million (2015-2020)
  • Table 91. Canada Anatomic Pathology, by Type USD Million (2015-2020)
  • Table 92. Canada Anatomic Pathology, by Application USD Million (2015-2020)
  • Table 93. Canada Anatomic Pathology, by End User USD Million (2015-2020)
  • Table 94. Mexico Anatomic Pathology, by Type USD Million (2015-2020)
  • Table 95. Mexico Anatomic Pathology, by Application USD Million (2015-2020)
  • Table 96. Mexico Anatomic Pathology, by End User USD Million (2015-2020)
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Anatomic Pathology: by Type(USD Million)
  • Table 110. Anatomic Pathology Instruments (Tissue Processors, Microtome, Cryostats, Others) , by Region USD Million (2021-2026)
  • Table 111. Anatomic Pathology Consumables (Reagents(Stains & Dyes,Fixatives,Others), Antibodies) , by Region USD Million (2021-2026)
  • Table 112. Anatomic Pathology Histopathology , by Region USD Million (2021-2026)
  • Table 113. Anatomic Pathology: by Application(USD Million)
  • Table 114. Anatomic Pathology Diseases Diagnosis , by Region USD Million (2021-2026)
  • Table 115. Anatomic Pathology Drug Discovery & Development , by Region USD Million (2021-2026)
  • Table 116. Anatomic Pathology Other Applications , by Region USD Million (2021-2026)
  • Table 117. Anatomic Pathology: by End User(USD Million)
  • Table 118. Anatomic Pathology Pathology Labs , by Region USD Million (2021-2026)
  • Table 119. Anatomic Pathology Research Institutes , by Region USD Million (2021-2026)
  • Table 120. Anatomic Pathology Hospitals , by Region USD Million (2021-2026)
  • Table 121. Anatomic Pathology Others , by Region USD Million (2021-2026)
  • Table 122. South America Anatomic Pathology, by Country USD Million (2021-2026)
  • Table 123. South America Anatomic Pathology, by Type USD Million (2021-2026)
  • Table 124. South America Anatomic Pathology, by Application USD Million (2021-2026)
  • Table 125. South America Anatomic Pathology, by End User USD Million (2021-2026)
  • Table 126. Brazil Anatomic Pathology, by Type USD Million (2021-2026)
  • Table 127. Brazil Anatomic Pathology, by Application USD Million (2021-2026)
  • Table 128. Brazil Anatomic Pathology, by End User USD Million (2021-2026)
  • Table 129. Argentina Anatomic Pathology, by Type USD Million (2021-2026)
  • Table 130. Argentina Anatomic Pathology, by Application USD Million (2021-2026)
  • Table 131. Argentina Anatomic Pathology, by End User USD Million (2021-2026)
  • Table 132. Rest of South America Anatomic Pathology, by Type USD Million (2021-2026)
  • Table 133. Rest of South America Anatomic Pathology, by Application USD Million (2021-2026)
  • Table 134. Rest of South America Anatomic Pathology, by End User USD Million (2021-2026)
  • Table 135. Asia Pacific Anatomic Pathology, by Country USD Million (2021-2026)
  • Table 136. Asia Pacific Anatomic Pathology, by Type USD Million (2021-2026)
  • Table 137. Asia Pacific Anatomic Pathology, by Application USD Million (2021-2026)
  • Table 138. Asia Pacific Anatomic Pathology, by End User USD Million (2021-2026)
  • Table 139. China Anatomic Pathology, by Type USD Million (2021-2026)
  • Table 140. China Anatomic Pathology, by Application USD Million (2021-2026)
  • Table 141. China Anatomic Pathology, by End User USD Million (2021-2026)
  • Table 142. Japan Anatomic Pathology, by Type USD Million (2021-2026)
  • Table 143. Japan Anatomic Pathology, by Application USD Million (2021-2026)
  • Table 144. Japan Anatomic Pathology, by End User USD Million (2021-2026)
  • Table 145. India Anatomic Pathology, by Type USD Million (2021-2026)
  • Table 146. India Anatomic Pathology, by Application USD Million (2021-2026)
  • Table 147. India Anatomic Pathology, by End User USD Million (2021-2026)
  • Table 148. South Korea Anatomic Pathology, by Type USD Million (2021-2026)
  • Table 149. South Korea Anatomic Pathology, by Application USD Million (2021-2026)
  • Table 150. South Korea Anatomic Pathology, by End User USD Million (2021-2026)
  • Table 151. Taiwan Anatomic Pathology, by Type USD Million (2021-2026)
  • Table 152. Taiwan Anatomic Pathology, by Application USD Million (2021-2026)
  • Table 153. Taiwan Anatomic Pathology, by End User USD Million (2021-2026)
  • Table 154. Australia Anatomic Pathology, by Type USD Million (2021-2026)
  • Table 155. Australia Anatomic Pathology, by Application USD Million (2021-2026)
  • Table 156. Australia Anatomic Pathology, by End User USD Million (2021-2026)
  • Table 157. Rest of Asia-Pacific Anatomic Pathology, by Type USD Million (2021-2026)
  • Table 158. Rest of Asia-Pacific Anatomic Pathology, by Application USD Million (2021-2026)
  • Table 159. Rest of Asia-Pacific Anatomic Pathology, by End User USD Million (2021-2026)
  • Table 160. Europe Anatomic Pathology, by Country USD Million (2021-2026)
  • Table 161. Europe Anatomic Pathology, by Type USD Million (2021-2026)
  • Table 162. Europe Anatomic Pathology, by Application USD Million (2021-2026)
  • Table 163. Europe Anatomic Pathology, by End User USD Million (2021-2026)
  • Table 164. Germany Anatomic Pathology, by Type USD Million (2021-2026)
  • Table 165. Germany Anatomic Pathology, by Application USD Million (2021-2026)
  • Table 166. Germany Anatomic Pathology, by End User USD Million (2021-2026)
  • Table 167. France Anatomic Pathology, by Type USD Million (2021-2026)
  • Table 168. France Anatomic Pathology, by Application USD Million (2021-2026)
  • Table 169. France Anatomic Pathology, by End User USD Million (2021-2026)
  • Table 170. Italy Anatomic Pathology, by Type USD Million (2021-2026)
  • Table 171. Italy Anatomic Pathology, by Application USD Million (2021-2026)
  • Table 172. Italy Anatomic Pathology, by End User USD Million (2021-2026)
  • Table 173. United Kingdom Anatomic Pathology, by Type USD Million (2021-2026)
  • Table 174. United Kingdom Anatomic Pathology, by Application USD Million (2021-2026)
  • Table 175. United Kingdom Anatomic Pathology, by End User USD Million (2021-2026)
  • Table 176. Netherlands Anatomic Pathology, by Type USD Million (2021-2026)
  • Table 177. Netherlands Anatomic Pathology, by Application USD Million (2021-2026)
  • Table 178. Netherlands Anatomic Pathology, by End User USD Million (2021-2026)
  • Table 179. Rest of Europe Anatomic Pathology, by Type USD Million (2021-2026)
  • Table 180. Rest of Europe Anatomic Pathology, by Application USD Million (2021-2026)
  • Table 181. Rest of Europe Anatomic Pathology, by End User USD Million (2021-2026)
  • Table 182. MEA Anatomic Pathology, by Country USD Million (2021-2026)
  • Table 183. MEA Anatomic Pathology, by Type USD Million (2021-2026)
  • Table 184. MEA Anatomic Pathology, by Application USD Million (2021-2026)
  • Table 185. MEA Anatomic Pathology, by End User USD Million (2021-2026)
  • Table 186. Middle East Anatomic Pathology, by Type USD Million (2021-2026)
  • Table 187. Middle East Anatomic Pathology, by Application USD Million (2021-2026)
  • Table 188. Middle East Anatomic Pathology, by End User USD Million (2021-2026)
  • Table 189. Africa Anatomic Pathology, by Type USD Million (2021-2026)
  • Table 190. Africa Anatomic Pathology, by Application USD Million (2021-2026)
  • Table 191. Africa Anatomic Pathology, by End User USD Million (2021-2026)
  • Table 192. North America Anatomic Pathology, by Country USD Million (2021-2026)
  • Table 193. North America Anatomic Pathology, by Type USD Million (2021-2026)
  • Table 194. North America Anatomic Pathology, by Application USD Million (2021-2026)
  • Table 195. North America Anatomic Pathology, by End User USD Million (2021-2026)
  • Table 196. United States Anatomic Pathology, by Type USD Million (2021-2026)
  • Table 197. United States Anatomic Pathology, by Application USD Million (2021-2026)
  • Table 198. United States Anatomic Pathology, by End User USD Million (2021-2026)
  • Table 199. Canada Anatomic Pathology, by Type USD Million (2021-2026)
  • Table 200. Canada Anatomic Pathology, by Application USD Million (2021-2026)
  • Table 201. Canada Anatomic Pathology, by End User USD Million (2021-2026)
  • Table 202. Mexico Anatomic Pathology, by Type USD Million (2021-2026)
  • Table 203. Mexico Anatomic Pathology, by Application USD Million (2021-2026)
  • Table 204. Mexico Anatomic Pathology, by End User USD Million (2021-2026)
  • Table 205. Research Programs/Design for This Report
  • Table 206. Key Data Information from Secondary Sources
  • Table 207. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Anatomic Pathology: by Type USD Million (2015-2020)
  • Figure 5. Global Anatomic Pathology: by Application USD Million (2015-2020)
  • Figure 6. Global Anatomic Pathology: by End User USD Million (2015-2020)
  • Figure 7. South America Anatomic Pathology Share (%), by Country
  • Figure 8. Asia Pacific Anatomic Pathology Share (%), by Country
  • Figure 9. Europe Anatomic Pathology Share (%), by Country
  • Figure 10. MEA Anatomic Pathology Share (%), by Country
  • Figure 11. North America Anatomic Pathology Share (%), by Country
  • Figure 12. Global Anatomic Pathology share by Players 2020 (%)
  • Figure 13. Global Anatomic Pathology share by Players (Top 3) 2020(%)
  • Figure 14. Global Anatomic Pathology share by Players (Top 5) 2020(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. F. Hoffmann-La Roche Ltd. (Switzerland) Revenue, Net Income and Gross profit
  • Figure 17. F. Hoffmann-La Roche Ltd. (Switzerland) Revenue: by Geography 2020
  • Figure 18. Danaher Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 19. Danaher Corporation (United States) Revenue: by Geography 2020
  • Figure 20. Thermo Fisher Scientific Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 21. Thermo Fisher Scientific Inc. (United States) Revenue: by Geography 2020
  • Figure 22. Hologic, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 23. Hologic, Inc. (United States) Revenue: by Geography 2020
  • Figure 24. Koninklijke Philips N.V.( Netherlands) Revenue, Net Income and Gross profit
  • Figure 25. Koninklijke Philips N.V.( Netherlands) Revenue: by Geography 2020
  • Figure 26. Agilent Technologies (United States) Revenue, Net Income and Gross profit
  • Figure 27. Agilent Technologies (United States) Revenue: by Geography 2020
  • Figure 28. Becton, Dickinson, and Company (United States) Revenue, Net Income and Gross profit
  • Figure 29. Becton, Dickinson, and Company (United States) Revenue: by Geography 2020
  • Figure 30. Sakura Finetek (Japan) Revenue, Net Income and Gross profit
  • Figure 31. Sakura Finetek (Japan) Revenue: by Geography 2020
  • Figure 32. Merck KGaA (Germany) Revenue, Net Income and Gross profit
  • Figure 33. Merck KGaA (Germany) Revenue: by Geography 2020
  • Figure 34. Bio SB (United States) Revenue, Net Income and Gross profit
  • Figure 35. Bio SB (United States) Revenue: by Geography 2020
  • Figure 36. Diapath S.p.A. (Italy) Revenue, Net Income and Gross profit
  • Figure 37. Diapath S.p.A. (Italy) Revenue: by Geography 2020
  • Figure 38. BioGenex Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 39. BioGenex Laboratories (United States) Revenue: by Geography 2020
  • Figure 40. Global Anatomic Pathology: by Type USD Million (2021-2026)
  • Figure 41. Global Anatomic Pathology: by Application USD Million (2021-2026)
  • Figure 42. Global Anatomic Pathology: by End User USD Million (2021-2026)
  • Figure 43. South America Anatomic Pathology Share (%), by Country
  • Figure 44. Asia Pacific Anatomic Pathology Share (%), by Country
  • Figure 45. Europe Anatomic Pathology Share (%), by Country
  • Figure 46. MEA Anatomic Pathology Share (%), by Country
  • Figure 47. North America Anatomic Pathology Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Danaher Corporation (United States)
  • Thermo Fisher Scientific Inc. (United States)
  • Hologic, Inc. (United States)
  • Koninklijke Philips N.V.( Netherlands)
  • Agilent Technologies (United States)
  • Becton, Dickinson, and Company (United States)
  • Sakura Finetek (Japan)
  • Merck KGaA (Germany)
  • Bio SB (United States)
  • Diapath S.p.A. (Italy)
  • BioGenex Laboratories (United States)
Additional players considered in the study are as follows:
Oxford Cancer Biomarkers Ltd. (United Kingdom) , Enzo Biochem Inc. (United States) , Epic Sciences (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation